Abstract: A new pharmaceutical compound for treating central nervous disorders, the compound comprising a therapeutically effective amount of valproic acid or pharmaceutically acceptable derivative thereof covalently bonded to myo-inositol. The invention also provides a composition, method for treating a patient and a method for obtaining the compound.
Type:
Grant
Filed:
March 15, 2006
Date of Patent:
July 27, 2010
Assignees:
Medipharma S.A., University Nacional De La Plata